Center for Financial Planning’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$136 Hold
10
﹤0.01% 640
2026
Q1
$60 Sell
10
-298
-97% -$2.24K ﹤0.01% 645
2025
Q4
$2.21K Hold
308
﹤0.01% 605
2025
Q3
$3.29K Hold
308
﹤0.01% 568
2025
Q2
$2.98K Hold
308
﹤0.01% 538
2025
Q1
$4.59K Hold
308
﹤0.01% 537
2024
Q4
$4.6K Hold
308
﹤0.01% 488
2024
Q3
$5.89K Sell
308
-20
-6% -$415 ﹤0.01% 448
2024
Q2
$6.79K Sell
328
-2
-0.6% -$40 ﹤0.01% 432
2024
Q1
$6.2K Sell
330
-6
-2% -$103 ﹤0.01% 455
2023
Q4
$4.85K Hold
336
﹤0.01% 422
2023
Q3
$5.83K Hold
336
﹤0.01% 408
2023
Q2
$6.99K Sell
336
-20
-6% -$435 ﹤0.01% 420
2023
Q1
$8.37K Hold
356
﹤0.01% 376
2022
Q4
$9.94K Sell
356
-217
-38% -$5.55K ﹤0.01% 359
2022
Q3
$13K Sell
573
-1
-0.2% -$30 ﹤0.01% 331
2022
Q2
$19K Sell
574
-195
-25% -$6.83K ﹤0.01% 296
2022
Q1
$27K Buy
769
+59
+8% +$2.02K 0.01% 285
2021
Q4
$22K Buy
710
+61
+9% +$1.99K ﹤0.01% 302
2021
Q3
$21K Sell
649
-330
-34% -$10.6K 0.01% 302
2021
Q2
$30K Buy
+979
New +$32.2K 0.01% 269

Other funds holding OGN

Center for Financial Planning's OGN Position: Q2 2026 in Review

Center for Financial Planning held its Organon & Co (OGN) position steady in Q2 2026 at 10 shares worth $136. The position accounts for ﹤0.01% of the portfolio, ranked #640.

Center for Financial Planning first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $30K in Q2 2021. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Center for Financial Planning held 10 shares of Organon & Co worth $136 as of Q2 2026.
  • Center for Financial Planning left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Center for Financial Planning's portfolio in Q2 2026, its #640 holding.
  • Center for Financial Planning first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Center for Financial Planning's Organon & Co position peaked at $30K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.